Anaphylaxis: recognition & treatment
Stepwise recognition, first-line IM epinephrine, positioning, escalation, tryptase, and disposition. Links the IM epinephrine dose, Ring-Messmer grading, tryptase 20%+2, REMA, WHO/ICC SM criteria, and neffy-weight calculators.
Evidence tier: Guideline-derived.
Decision points
- Meets anaphylaxis criteria?
- Response to treatment?
- High biphasic / extended-monitoring risk?
- Obtain tryptase?
Do-not-miss pitfalls
- Do not use isolated urticaria as automatic anaphylaxis unless multisystem or severe features exist.
- Do not delay epinephrine for antihistamines or corticosteroids.
- Normal tryptase does not rule out anaphylaxis, especially food-triggered reactions.
- Do not assume a first known exposure excludes anaphylaxis, prior unrecognized sensitization can occur.
- Avoid blanket discontinuation of beta-blockers/ACE inhibitors without weighing cardiovascular risk.
- Sitting or standing a patient in shock can cause fatal pulseless electrical activity, keep supine with legs elevated until fully stable.
- Corticosteroids are NOT reliably effective for preventing biphasic anaphylaxis; the 2023 parameter removed the recommendation.
- IV epinephrine outside a monitored setting carries high risk of fatal arrhythmia, use IM route until continuous cardiac monitoring is established.
- Alpha-galactose (α-gal) syndrome causes delayed anaphylaxis 2-6 h after red meat in patients sensitized by lone star tick bites, onset during sleep is a clue; do not label as idiopathic without asking about tick exposure and meat timing.
- Scombroid fish poisoning (improperly refrigerated tuna, mackerel, mahi-mahi) produces histamine-mediated flushing, urticaria, and vomiting that mimic anaphylaxis, epinephrine is safe to give if uncertain, but the reaction is not IgE-mediated and will not recur with future fish exposure.
- Protracted anaphylaxis (symptoms persisting >4 h despite initial epinephrine) is distinct from biphasic reaction, often signifies persistent allergen exposure or inadequate treatment and typically requires IV epinephrine infusion and ICU-level monitoring.
Evidence & citations
- Golden DBK, Wang J, Waserman S, et al. Anaphylaxis: A 2023 practice parameter update. Ann Allergy Asthma Immunol. 2024;132(2):124-176. PMID 38108678
- Cardona V, Ansotegui IJ, Ebisawa M, et al. World Allergy Organization Anaphylaxis Guidance 2020. World Allergy Organ J. 2020;13(10):100472. PMID 33204386
- Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis, a 2020 practice parameter update. J Allergy Clin Immunol. 2020;145(4):1082-1123. PMID 32001253
- Simons FE, Ardusso LR, Bilò MB, et al. World Allergy Organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J. 2011;4(2):13-37. PMID 23268454
- Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol. 2006;117(2):391-397. PMID 16461139
Clinician decision support. Verify against the cited source. Not a substitute for clinical judgment. 100% on-device; no patient data is stored or transmitted.